Facebook
Twitter
Telegram
Report an ErrorBiofrontera AG Financial Statements 2011-2024 | BFRA
Annual Financial Statements Biofrontera AG
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
220 M | 251 M | 291 M | - | - | - | - | - | - | - |
Shares |
27.8 M | 22.3 M | 21.8 M | - | - | - | - | - | - | - |
Net Income |
-13 M | -7.64 M | -8.88 M | -16.1 M | -10.6 M | -11.2 M | -10.7 M | -8.07 M | -4.12 M | -4.64 M |
Revenue |
30.3 M | 31.3 M | 21.1 M | 12 M | 6.13 M | 4.14 M | 3.1 M | 3.11 M | 3.43 M | 515 K |
EBITDA |
-2.28 M | -20.2 M | -17.7 M | -13 M | -10.9 M | -9.42 M | -8.72 M | -6.4 M | -2.91 M | -4.01 M |
Operating Expenses |
34.4 M | 49.8 M | 35.1 M | 24.2 M | 16.3 M | 13.1 M | 11.5 M | 8.65 M | 5.48 M | 4.44 M |
General and Administrative Expenses |
9.15 M | 16.3 M | 13 M | 3.1 M | 2.85 M | 2.76 M | 3.12 M | 5.46 M | 4.09 M | 3.04 M |
All numbers in USD currency